News | Enterprise Imaging | December 01, 2020

Momentum Continues for Visage at RSNA 2020

Visage 7 Live Connect enables simple radiologist collaboration with referrers

Visage 7 Live Connect enables simple radiologist collaboration with referrers

December 1, 2020 — Visage Imaging, Inc. ("Visage"), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced it will be showcasing the latest version of the Visage 7 Enterprise Imaging Platform, featuring the introduction of Visage 7 Live Connect (as a works-in-progress), at the virtual Radiological Society of North America (RSNA) 2020 annual meeting, from Sunday, November 29 – Saturday, December 5, 2020.

Visage has proven especially resilient during the global pandemic. The company's leading-edge technology enables radiologists to read remotely with lightning-fast speed and diagnostic precision regardless of the size or type of examination(s). Go-lives for both on-premise and public-cloud based implementations have continued throughout, underpinned by the company's ability to provide remote training and support regardless of the scale or complexity of the implementation. This has further strengthened Visage's reputation for seamless replacement of legacy PACS.

Healthcare institutions are seeking modern, flexible solutions and have a heightened awareness of security due to the increasing threat of malware and ransomware attacks. These factors, in combination with the relentless growth of imaging datasets, continue to present architectural and performance hurdles for imaging organizations reliant on legacy PACS with 'compress and send' limitations and inferior server-side technology.

"Today's Enterprise Imaging challenges institutions with constantly evolving requirements," explained Malte Westerhoff, Ph.D., Visage Imaging Co-Founder and Chief Technology Officer. Westerhoff continued, "At Visage, we continue to implement leading design principles with Visage 7 that enhance capabilities, improve performance and tighten security. This allows our customers to remain a step ahead of their increasing clinical needs and the threats that they must navigate. Visage continues to innovate with significant velocity, rapidly getting new features into clinical use. With Visage 7 Live Connect, we're enabling radiologists to easily share images with referring physicians during interpretation, without disruption to diagnostic reading workflow. The simplicity of collaboration will encourage radiologists to utilize imaging communications in ways that were previously not thought possible, to include the potential for collaboration with patients and their imaging."

At RSNA 2020, the following highlights will be demonstrated and discussed:

  • Visage 7 Live Connect. Visage 7 Live Connect empowers collaboration, making real-time communications easy. Radiologists will be able to immediately and securely collaborate, sharing images with referrers directly from Visage 7 during interpretation workflow. The radiologist will simply pass a secure link and session code to all intended recipients for real-time viewing from any HTML browser using any of their preferred devices (e.g., desktop, mobile, tablet). Even though radiologists typically use multiple high-resolution diagnostic displays, and referring physicians may use a single display or a mobile device, Visage 7 Live Connect is not restricted due to any potential display or device type mismatch. Instead, collaborative image viewing is optimally focused on the radiologist's active viewer, does not require recipient users have any installed software or account(s) on Visage 7, and all recipients are able to view shared cursor movements from one or multiple screen share participants.
  • Transcatheter Aortic Valve Replacement (TAVR) Planning. Demonstrated as a works-in-progress, Visage 7 supports a new Triangle tool for TAVR planning. This tool automatically repositions all of the MPR viewers, so the axial view is in plane with the valve where the leaflets join. This rapidly allows the radiologist to drop 3 points simplifying the capture of TAVR planning measurements.
  • Visage In The Cloud - SAML. Visage 7 now natively supports the Security Assertion Markup Language (SAML) open standard for secure single-sign on (SSO) solutions with an identity provider for public cloud implementations of Visage 7.
  • Visage AI Accelerator – Iterative Learning Cycle. The Visage AI Accelerator is an end-to-end AI solution that bridges both research and diagnostic imaging with the same, unified platform. Visage will demonstrate and discuss how Visage 7 plays a central, integrated role in the AI pipeline, accelerating iterative learning and ground truth development with innovative native tools, fostering an optimized train/validate/enhance cycle.

Visage is also a proud participant in the Imaging AI in Practice (IAIP) demonstration, a multi-vendor interoperability demonstration highlighting new technologies and communications standards needed to integrate AI into the diagnostic radiology workflow. Click here to view the IAIP demonstration's "Evolve with AI" video, found in the RSNA 2020 AI Showcase [Note: RSNA 2020 registration is required for viewing].

Visage's virtual RSNA 2020 exhibit is available to registered attendees via this direct link. To schedule a priority virtual demonstration of Visage 7 at RSNA 2020, please click here for additional details. Experience Visage's all-new website here.

Related Content

More complex, longer interventional procedures such as structural heart interventions or this revascularization of a coronary chronic total occlusion (CTO) at Henry Ford Hospital in Detroit, requires angiography imaging systems that have improved image detail and lower radiation dose. However, purchase of new systems was put on hold by many hospitals in 2020 due to the sudden drop in elective procedures and diversion of resources due to the COVID-19. Photo by Dave Fornell.

More complex, longer interventional procedures such as structural heart interventions or this revascularization of a coronary chronic total occlusion (CTO) at Henry Ford Hospital in Detroit, requires angiography imaging systems that have improved image detail and lower radiation dose. However, purchase of new systems was put on hold by many hospitals in 2020 due to the sudden drop in elective procedures and diversion of resources due to the COVID-19. Photo by Dave Fornell.

Feature | Angiography | January 19, 2021 | By Bhvita Jani
January 19, 2021 – With the postponement of non-essential elective surgeries and medical procedures in 2020 to conser
AI Metrics, LLC, a medical imaging startup focused on augmented intelligence to improve patient care, announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s flagship image analysis platform.
News | Artificial Intelligence | January 18, 2021
January 18, 2021 — AI Metrics, LLC, a medical imaging startup focused on augmented intelligence to improve patient ca
MRI of Nonferromagnetic Ballistics Suspended in Gelatin. 

MRI of Nonferromagnetic Ballistics Suspended in Gelatin. Scout (A), T1-weighted spin-echo (SE) (B), T2-weighted SE (C), T2-weighted gradient-recalled echo (GRE) (TR/TE, 500/10; D), and T2-weighted GRE (TR/TE, 700/30; E) MR images show jacket hollow point .45 automatic Colt pistol bullet (Corbon) (1), solid lead .45 Long Colt bullet (Winchester) (2), full metal jacket (FMJ) automatic Colt pistol bullet (Winchester) (3), 5.56-mm FMJ bullet (Federal Ammunition) (4), #7 lead shotgun pellet (Winchester) (5), and 5-mm lead air gun pellet (Sheridan) (6). On all sequences, metallic artifact is minimal. Although metallic artifact increases or blooms with increased TR/TE in GRE images (D and E), amount of surrounding distortion is still minimal.

News | Magnetic Resonance Imaging (MRI) | January 15, 2021
January 15, 2021 — 
Novel Coronavirus SARS-CoV-2 Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: National Institute of Allergy and Infectious Diseases, NIH

Novel Coronavirus SARS-CoV-2 Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Image courtesy of  National Institute of Allergy and Infectious Diseases (NIH)

News | Coronavirus (COVID-19) | January 15, 2021
January 15, 2021 — In one of the first studies to examine the impact of the...
Multidisciplinary functionality supports high-capacity utilization and economic efficiency
News | Mobile C-Arms | January 14, 2021
January 14, 2021 — Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the...
Use of telehealth jumped sharply during the first months of the coronavirus pandemic shutdown, with the approach being used more often for behavioral health services than for medical care, according to a new RAND Corporation study.

Getty Images

News | Teleradiology | January 13, 2021
January 13, 2021 — Use of telehealth jumped sha
The U.S. Food and Drug Administration released the agency's first Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. This action plan describes a multi-pronged approach to advance the Agency's oversight of AI/ML-based medical software.
News | Artificial Intelligence | January 12, 2021
January 12, 2021 — The U.S.
Myocarditis among recovering COVID-19 athletes less common than previously reported

Getty Images

News | Cardiac Imaging | January 11, 2021
January 11, 2021 — In a letter published in the December issue of the American Heart Association's...